Global Heart Failure Testing Market Growth (Status and Outlook) 2025-2031

According to this study, the global Heart Failure Testing market size will reach US$ million by 2031.

Heart failure is due to the contraction of the heart function and (or) diastolic function obstacle, blood vein change can not be fully out of the heart, lead to venous blood pooling system, arterial blood perfusion system is insufficient, causing cardiovascular disorders, the disorder syndrome focuses for pulmonary congestion, vena cava blood clot.

United States market for Heart Failure Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Heart Failure Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Heart Failure Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Heart Failure Testing players cover Abbott, Response Biomedical, Roche, Trinity Biotech, Quidel, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Heart Failure Testing Industry Forecast” looks at past sales and reviews total world Heart Failure Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Heart Failure Testing sales for 2025 through 2031. With Heart Failure Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Heart Failure Testing industry.

This Insight Report provides a comprehensive analysis of the global Heart Failure Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Heart Failure Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Heart Failure Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Heart Failure Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Heart Failure Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Heart Failure Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Electrocardiogram Testing
Blood Testing
Others

Segmentation by Application:
Hospitals
Diagnostic Laboratories
Cardiac Care Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Response Biomedical
Roche
Trinity Biotech
Quidel
Siemens
bioMérieux
GE
Philips

Please note: The report will take approximately 2 business days to prepare and deliver. Show more